HIV-Prevention Education for University Student Health Centers
Meeting Slides
Clinical Practice Guidelines
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.
US Department of Health and Human Services, revised 2018.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.
US Department of Health and Human Services, last updated May 30, 2018.
Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Provider’s Supplement
Centers for Disease Control and Prevention, 2017.
Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens.
Centers for Disease Control and Prevention, 2018.
STD and HIV Screening Recommendations.
Centers for Disease Control and Prevention, 2017.
Clinical Resources
American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.
Basic Statistics.
Centers for Disease Control and Prevention, July 2018.
Brief Sexual History Tool.
Centers for Disease Control and Prevention.
Database of Antiretroviral Drug Interactions.
HIV InSite. University of California, San Francisco.
Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV.
Centers for Disease Control and Prevention, 2017.
HIV Among Youth.
Centers for Disease Control and Prevention, 2018.
HIV Drug Interactions.
University of Liverpool (Web site), 2017.
HIV in the United States by Region.
Centers for Disease Control and Prevention, 2017.
HIV Surveillance Supplemental Report.
Centers for Disease Control and Prevention, 2018.
HIV Surveillance Fact Sheet, Georgia, 2015.
Georgia Department of Public Health, April 2017.
National College Health Assessment II.
American College Health Association, 2013.
PrEP Kit.
AIDS United, 2015.
Provider Information Sheet: PrEP During Conception, Pregnancy, and Breastfeeding.
Centers for Disease Control and Prevention.
Sexually Transmitted Diseases Treatment Guidelines.
Centers for Disease Control and Prevention, 2015.
State HIV Laws.
Centers for Disease Control and Prevention, 2018.
Taking a Sexual History.
NYC Health, 2015.
Transgender Health Learning Center.
University of California, San Francisco, 2018.
Partner Organizations
Above the Status Quo
Georgia AIDS Education and Training Center
Patient Resources
Centers for Disease Control and Prevention (CDC): HIV Basics.
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).
HIV Risk Reduction Tool.
Centers for Disease Control and Prevention.
Pill-Reminder Smartphone Apps (Free)
Mango Health – Medicine Reminder and Manager for iPhone.
Medisafe Medicine Reminders & Tracker for iPhone.
Medisafe Pill Reminder & Medication Tracker for Android.
Positively Aware.
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.
PrEP for U.S. Women: A Collection of Resources.
HIVE provides preconception and prenatal care and resources for women and couples affected by HIV
Suggested Readings
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Benefit of continuous/immediate ART on disease risk: SMART & START combined analysis.
Borges AH, et al. 24th Conference on Retroviruses and Opportunistic Infections; February 13−16, 2017; Seattle, WA. Abstract 474.
Frequency of HIV testing and time from infection to diagnosis improve.
Centers for Disease Control and Prevention, 2017.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Being PrEPared – preexposure prophylaxis and HIV disparities.
Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
Challenges in translating PrEP interest into uptake in an observational study of young black MSM.
Rolle CP, et al. J Acquir Immun Defic Syndr. 2017;76(3):250-258.
Willingness to use pre-exposure prophylaxis among black and white men who have sex with men in Atlanta, Georgia.
Rolle CP, et al. Int J STD AIDS. 2017;28(9):849-857.
Initiation of antiretroviral therapy in early asymptomatic HIV infection.
The INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-80.
Interactive PresentationPrEP HIV Pre-Exposure Prophylaxis
Narrated by Raphael J. Landovitz, MD
Sexual History
Narrated by Raphael J. Landovitz, MD
Introducing PrEP and Determining Eligibility
Narrated by Raphael J. Landovitz, MD
Pre-PrEP Patient Education
Narrated by Raphael J. Landovitz, MD
PrEP Monitoring ond Ongoing Counseling
Narrated by Raphael J. Landovitz, MD
Are you PrEP’d to Discuss Sexual Health & HIV Prevention?
This innovative live activity is designed for PCPs to practice their skills in sexual health discussions and HIV prevention via a simulated tele-visit with a standardized patient, trained to simulate the signs, symptoms, and behaviors of patients seen in daily practice. Earn 0.5 CME/CE credit. Click here for more information!
Relevant Resources
Individualized Management in Primary Care
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
The PCPs Role in Preventing HIV
The PCP’s Role in Timely Recognition and Referral
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
Improving Patient Outcomes Through Shared Clinical Decision Making
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
Mechanistic Insights and Evolving Treatment Options
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Clinical Resource Center
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
A PrEP Primer
A Foundation for Managed Care
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Unlocking Novel Paths to Patient Care
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
The Increasing Role of JAK Inhibitors
Preventing COPD Exacerbations to Improve Outcomes
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
A Whole Patient Case Series
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Getting on the Fast Track to Identify AxSpA
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
Updates, Clinical Scenarios, and Future Directions
A Multidisciplinary Look at Early Diagnosis and Management
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
Are You Aware of New Blood-Based Multi-Cancer Screening Tools
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Strengthening Your Knowledge of Blood-Based Screening Tools
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
What You Need to Know About New Blood-Based Screening Tools
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
Practical Updates on the 2023 GOLD Guidelines
A Phone-a-Friend CME Series – Volume 2
Incorporating New Data and Updated Guidelines Into Daily Practice
Focus on Psoriasis
Capitalizing on BCMA-Directed Therapies
